Many health systems are considering increasing price transparency at the time of order entry. However, evidence of its impact on clinician ordering behavior is inconsistent and limited to single-site evaluations of shorter duration. The objective is to test the effect of displaying Medicare allowable fees for inpatient laboratory tests on clinician ordering behavior over 1 year.